Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Ban on Novartis Flu Vaccine Lifted in Switzerland, Canada | |
|
| |
After determining the safety and efficiency of flu vaccines made by Swiss pharmaceutical giant Novartis, Swiss and Canadian health authorities on Wednesday lifted a ban on sales of the flu vaccine.
"The partially visible white particles are in no way external impurities, but are agglutinations of ordinary protein components of the vaccine," Switzerland's national drug agency Swissmedic said in a statement.
Novartis provided what it said was a statement from the Canadian authorities.
The Public Health Agency of Canada said in the statement it had lifted their freeze after determining they were safe, saying it was "now advising health care professionals in possession of these vaccines that they can start using them once again."
Last week, Italy first froze the sale and use of Novartis's Fluad and Begripal flu vaccines after white particles were seen in syringes carrying them, and Switzerland, Austria, Germany, France, Spain and Canada soon followed suit.
Swissmedic stressed Wednesday though that "such (particles) can in effect be created during the manufacturing of the vaccine, but dissolve if the syringe is used in conformity with instructions," pointing out that the syringe should be lightly shaken before use.
"The security and efficiency of the vaccine are in no way weakened by these (particles) present in some syringes," it said, adding that its own labs had tested the vaccines and had confirmed their quality.
Some 160,000 doses of the vaccines were affected by last week's freeze in Switzerland alone, according to Swissmedic.
Novartis said Wednesday it was "pleased" at Switzerland and Canada's decisions to resume use of its vaccines.
"We have always remained confident in the safety and efficacy of our vaccines," the company said, adding that it now was "working with the Swiss and Canadian Authorities to resume full distribution as soon as possible to protect against seasonal influenza."
"Novartis is working diligently with other health authorities to address their questions and resume distribution," it added.
Source-AFP
| |
|
|
 Comment & Contribute
|
Related Links
Annual Flu Vaccination may Protect the Heart as Well
A new study presented at the 2012 Canadian Cardiovascular Congress reveals that the annual flu vaccination could also reduce the risk of heart ...
To Protect Patients All Health Care Workers Must Take Mandatory Flu Vaccine
An editorial argues that all health care workers in health care institutions should be vaccinated with the annual influenza vaccine to protect ...
Sale and Use of Novartis Flu Vaccines Banned
Italy bans the use and sale of several flu vaccines produced by Swiss drugs group Novartis. "The health ministry and the Italian ...
Flu Vaccine may be Safely Administered to Children With Egg Allergy: Study
The H1N1 strain of the influenza A virus has been a common cause of influenza in the recent years. Vaccination against H1N1 can help to protect ...
Drug Related News
Experts Recommend US Approval of a New Merck Sleeping Pill
Independent panel of experts recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage ...
Common Drug for Depression Reduces Stress-related Heart Condition
Researchers at Duke Medicine have found that a drug commonly used to treat depression and anxiety may improve a stress-related heart condition in ...
New, Effective Sleeping Pill from Merck to Hit US Markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall asleep and stay asleep, say reviewers at the US Food and ...
EU Agency Says Acne Pill Benefits Outweigh Blood Clot Risk
The benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins, said Europe's ...
Reduce Ambien's Dose to Avoid Drowsy Driving
U.S. Food and Drug Administration has now given the nod for new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) with a view to ...
Statins Cut Exercise Benefits
Simvastatin a type of statin was found to hinder the positive effects of exercise for obese and overweight adults. Statins, the ...
- Health News Index
- News Quick Links
| News Categories: |
| » | Experts Recommend US Approval of a New Merck Sleeping Pill |
| » | Common Drug for Depression Reduces Stress-related Heart Condition |
| » | New, Effective Sleeping Pill from Merck to Hit US Markets |
| » | EU Agency Says Acne Pill Benefits Outweigh Blood Clot Risk |
| » | Reduce Ambien's Dose to Avoid Drowsy Driving |
| More Drug News | |
|
Ask an Expert
